• Fri, February 24, 2023
Yigal Nochomovitz Maintained (CALT) at Strong Buy with Increased Target to $79 on, Feb 24th, 2023
Yigal Nochomovitz of Citigroup, Maintained "Calliditas Therapeutics AB (publ)" (CALT) at Strong Buy with Increased Target from $76 to $79 on, Feb 24th, 2023.
Yigal, nor any peers, have made any analyst calls on CALT in the last 4 months.
Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30Like: 👍
